![Stephen Hahn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Hahn
Direktor/Vorstandsmitglied bei
ION BEAM APPLICATIONS, SA
Profil
Stephen M Hahn is currently the Chief Executive Officer at Nucleus Radiopharma, Inc. since 2025.
He is also a Director at Ion Beam Applications SA and Faeth Therapeutics, Inc., both positions starting in 2026.
Mr. Hahn completed undergraduate education at William Marsh Rice University and graduate education at Temple University (Pennsylvania).
Aktive Positionen von Stephen Hahn
| Unternehmen | Position | Beginn |
|---|---|---|
| ION BEAM APPLICATIONS, SA | Direktor/Vorstandsmitglied | 16.06.2026 |
| FAETH THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 12.06.2026 |
Nucleus Radiopharma, Inc.
 Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Vorstandsvorsitzender | 20.08.2025 |
Ausbildung von Stephen Hahn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
35
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Ion Beam Applications SA
 Ion Beam Applications SA Medical SpecialtiesHealth Technology Supplies medical, dental and hospital equipment | Health Technology |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Health Technology |
